Skip to main content

Abstract

Measurements of glucagon were performed in 31 patients with diabetic ketoacidosis before and during insulin therapy. Marked hyperglucagonemia was recorded in all patients. A significant correlation was found between the basal plasma levels of glucagon and those of glucose (r = 0.51, p <.05) and ketone bodies (r = 0.75, p <.01). The highest levels of glucagon were noted in the patients with non-ketotic hyperglycemia. Insulin therapy resulted in a significant suppression of glucagon levels which preceded any significant change in plasma glucose. Nevertheless, the correction of hyperglycemia occurred whilst absolute hyperglucagonemia still persisted. Although these results suggest that insulin has a direct inhibitory effect on glucagon secretion, they raise the question of the role of glucagon in the development of ketosis and hyperglycemia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Assan, R., Hautecouverture, G., Guillemant, S., Dauchy, F., Protin, P. and Dérot, M. (1969): Evolution de parametres hormonaux (glucagon, Cortisol, hormone somatotrope) et énergétiques (glucose, acides gras, glycerol libre) dans dix acido-cétoses diabétiques graves traitees. Path. Biol. 17, 1095–1105.

    CAS  Google Scholar 

  2. Barnes, A. J. and Bloom, S. R. (1976): Pancreatectomized man: a model for diabetes without glucagon. Lancet 1, 219–221.

    Article  PubMed  CAS  Google Scholar 

  3. Bergmeyer, H. V. (1973): Methods of Enzymatic Analysis, 2nd English Edition, Academic Press, New York.

    Google Scholar 

  4. Clark, M. G., Filsell, 0. H. and Jarrett, I. G. (1976): Gluconeogenesis in isolated intact lamb liver cells. Effects of glucagon and butyrate. Biochem. J. 156, 671–680.

    CAS  Google Scholar 

  5. Gerich, J. E., Lorenzi, M., Bier, D. M., Schneider, V., Tsalikian, E., Karam, J. H. and Forsham, P. H. (1975): Prevention of human diabetic ketoacidosis by somatostatin: evidence for an essential role of glucagon. New Engl. J. Med. 292, 985–989.

    Article  PubMed  CAS  Google Scholar 

  6. Kraegen, E. W., Lazarus, L., Meier, H., Campbell, L. and Chia, Y. O. (1975): Carrier solutions for low level intravenous insulin infusion. Brit. Med. J. 3, 464–466.

    Article  PubMed  CAS  Google Scholar 

  7. Lazarus, L., Kraegen, E. W., Campbell, L., Casey, J. H., Zacharin, M. and Wienholt, J. (1976): Submitted for publication.

    Google Scholar 

  8. Lindsey, C. A., Faloona, G. R. and Unger, R. H. (1974): Plasma glucagon in non-ketotic hyperosmolar coma. JAMA 229, 1771–1773.

    Article  PubMed  CAS  Google Scholar 

  9. Lundbaek, K., Christensen, S. E., Hansen, A. P., Iversen, J., Ørskov, H., Seyer-Hansen, K., Alberti, K. G. M. M. and Whitefoot, R. (1976): Failure of somatostatin to correct manifest diabetic ketoacidosis. Lancet 1, 215–218.

    Article  PubMed  CAS  Google Scholar 

  10. Marco, J., Calli, C., Roman, D., Diaz-Fierros, M., Villanueva, M. L. and Valverde, I. (1973): Hyperglucagonism induced by glucocorticoid treatment in man. New Engl. J. Med. 288, 128–132.

    Article  PubMed  CAS  Google Scholar 

  11. Müller, W. A., Faloona, G. R. and Unger, R. H. (1973): Hyperglucagonemia in diabetic ketoacidosis. Am. J. Med. 54, 52–57.

    Article  PubMed  Google Scholar 

  12. Unger, R. H. (1976): Diabetes and the alpha cell. Diabetes 25, 136–151.

    PubMed  CAS  Google Scholar 

  13. Wilcoxon, F. (1947): Probability tables for individual comparisons by ranking methods. Biometrics 3, 119–122.

    Article  Google Scholar 

  14. Samols, E., Tyler, J. M. and Marks, V. (1972): Glucagon-insulin inter-relationships. In: Glucagon. Molecular Physiology, Clinical and Therapeutic Implications. P. J. Lefebvre and R. H. Unger, Eds. Pergamon Press, New York, pp. 151–173.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1977 Springer-Verlag New York Inc.

About this paper

Cite this paper

Lazarus, L., Kraegen, E.W., Meler, H., Zacharin, M., Campbell, L., Casey, J.H. (1977). Glucagon in Diabetic Coma. In: Foà, P.P., Bajaj, J.S., Foà, N.L. (eds) GLUCAGON: Its Role in Physiology and Clinical Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-6366-1_44

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-6366-1_44

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-6368-5

  • Online ISBN: 978-1-4612-6366-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics